Aignostics

Series-B
aignostics.com Biotech & Healthcare Berlin, Germany Founded 2018 101–250 employees
Total Funding $54.0M
Latest Round $34M Series-B
Last Announced Oct 29, 2024
Investors 8 Backers
Decision Makers 6 Available

About Aignostics

Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Berlin, Germany
Year Founded 2018
Team Size 101–250 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website aignostics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @aignostics (188 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $34,000,000 · Series-B

    startupintros.com

  2. Capital Raise

    Raised $13,980,000 · Series-A

    Backed by Wellington Management

  3. Capital Raise

    Raised $6,000,000 · Seed

    Backed by Boehringer Ingelheim Venture Fund

  4. Milestone

    Company founded

    Berlin, Germany

Investors & Backers

8
Boehringer Ingelheim Venture Fund
Lead
Wellington Management
Lead
Ascenion GmbH
Carma Fund
Future Capital
HTGF
IBB Ventures
Mayo Clinic

Funding History

3 Rounds
Series-B equity · Oct 29, 2024
Series-A equity · Sep 15, 2022

Round backers: Wellington Management

Seed equity · Aug 1, 2020

Round backers: Boehringer Ingelheim Venture Fund

Founders & Leadership

4

Frederick Klauschen

Founder

Work email & phone locked Unlock →

Klaus-Robert Müller

Founder

Work email & phone locked Unlock →

Maximilian Alber

Founder

Work email & phone locked Unlock →

Viktor Matyas

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts